Polycyclic aromatic hydrocarbon (PAH)–DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study

Cancer Causes and Control

Volumn 26, Issue 12, 2015, Pages 1791-1802

  White, Alexandra J ^a   Chen, Jia ^b   McCullough, Lauren E ^a   Xu, Xinran ^c   Cho, Yoon Hee ^d   Teitelbaum, Susan L ^b   Neugut, Alfred I ^d   Terry, Mary Beth ^d   Hibshoosh, Hanina ^d   Santella, Regina M ^d   Gammon, Marilie D ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Tongji University   (China)

^d Columbia University ^*  (United States)

Author keywords

Breast cancer; DNA methylation; Polycyclic aromatic hydrocarbons

Indexed keywords

DNA; HORMONE RECEPTOR; POLYCYCLIC AROMATIC HYDROCARBON; RETINOID RELATED ORPHAN RECEPTOR BETA; DNA ADDUCT; POLYCYCLIC AROMATIC HYDROCARBONS-DNA ADDUCT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DNA ADDUCT; DNA METHYLATION; DNA MODIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE INTERACTION; GENETIC HETEROGENEITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; TERTIARY HEALTH CARE; UNITED STATES; VERY ELDERLY; ADVERSE EFFECTS; BREAST NEOPLASMS; GENETICS; INCIDENCE; MIDDLE AGED; ODDS RATIO; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA ADDUCTS; DNA METHYLATION; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; ODDS RATIO; POLYCYCLIC AROMATIC HYDROCARBONS; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84945485308     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0672-7     Document Type: Article

References (55)

1. American Cancer Society (2013) Cancer facts and figures 2013. American Cancer Society, Atlanta
2. Perera FP, Estabook A, Hewer A, Channing K, Rundle A, Mooney LA, Whyatt R, Phillips DH (1995) Carcinogen-DNA adducts in human breast-tissue. Cancer Epidemiol Biomarkers Prev 4(3):233–238
3. Rundle A, Tang DL, Hibshoosh H, Estabrook A, Schnabel F, Cao WF, Grumet S, Perera FP (2000) The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis 21(7):1281–1289. doi:10.1093/carcin/21.7.1281
4. Gammon MD, Sagiv SK, Eng SM, Shantakumar S, Gaudet MM, Teitelbaum SL, Britton JA, Terry MB, Wang LW, Wang Q, Stellman SD, Beyea J, Hatch M, Kabat GC, Wolff MS, Levin B, Neugut AI, Santella RM (2004) Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis. Arch Environ Health 59(12):640–649. doi:10.1080/00039890409602948
5. Gammon MD, Santella RM, Neugut AI, Eng SM, Teitelbaum SL, Paykin A, Levin B, Terry MB, Young TL, Wang LW, Wang Q, Britton JA, Wolff MS, Stellman SD, Hatch M, Kabat GC, Senie R, Garbowski G, Maffeo C, Montalvan P, Berkowitz G, Kemeny M, Citron M, Schnabel F, Schuss A, Hajdu S, Vinceguerra V (2002) Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev 11(8):677–685
6. Hecht SS (2002) Tobacco smoke carcinogens and breast cancer. Environ Mol Mutagen 39(2–3):119–126. doi:10.1002/em.10071
7. Boström CE, Gerde P, Hanberg A, Jernstrom B, Johansson C, Kyrklund T, Rannug A, Tornqvist M, Victorin K, Westerholm R (2002) Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 110(Suppl 3):451–488
8. Godschalk RW, Van Schooten FJ, Bartsch H (2003) A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. J Biochem Mol Biol 36(1):1–11
9. Xu X, Gammon MD, Hernandez-Vargas H, Herceg Z, Wetmur JG, Teitelbaum SL, Bradshaw PT, Neugut AI, Santella RM, Chen J (2012) DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J 26(6):2657–2666. doi:10.1096/fj.11-197251
10. Choi JY, James SR, Link PA, McCann SE, Hong CC, Davis W, Nesline MK, Ambrosone CB, Karpf AR (2009) Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 30(11):1889–1897. doi:10.1093/carcin/bgp143
11. Xu X, Gammon MD, Jefferson E, Zhang Y, Cho YH, Wetmur JG, Teitelbaum SL, Bradshaw PT, Terry MB, Garbowski G, Hibshoosh H, Neugut AI, Santella RM, Chen J (2011) The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study. Epigenetics 6(11):1276–1283. doi:10.4161/epi.6.11.17744;10.4161/epi.6.11.17744
12. Brennan K, Flanagan JM (2012) Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev Res (Phila) 5(12):1345–1357. doi:10.1158/1940-6207.capr-12-0316
13. Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13(7):484–492. doi:10.1038/nrg3230
14. Cho YH, Shen J, Gammon MD, Zhang YJ, Wang Q, Gonzalez K, Xu X, Bradshaw PT, Teitelbaum SL, Garbowski G, Hibshoosh H, Neugut AI, Chen J, Santella RM (2012) Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Res Treat 131(1):197–205. doi:10.1007/s10549-011-1712-y
15. Tang WY, Levin L, Talaska G, Cheung YY, Herbstman J, Tang D, Miller RL, Perera F, Ho SM (2012) Maternal exposure to polycyclic aromatic hydrocarbons and 5′-CpG methylation of interferon-gamma in cord white blood cells. Environ Health Perspect 120(8):1195–1200. doi:10.1289/ehp.1103744
16. Shenker NS, Ueland PM, Polidoro S, van Veldhoven K, Ricceri F, Brown R, Flanagan JM, Vineis P (2013) DNA methylation as a long-term biomarker of exposure to tobacco smoke. Epidemiology 24(5):712–716. doi:10.1097/EDE.0b013e31829d5cb3
17. Duan H, He Z, Ma J, Zhang B, Sheng Z, Bin P, Cheng J, Niu Y, Dong H, Lin H, Dai Y, Zhu B, Chen W, Xiao Y, Zheng Y (2013) Global and MGMT promoter hypomethylation independently associated with genomic instability of lymphocytes in subjects exposed to high-dose polycyclic aromatic hydrocarbon. Arch Toxicol 87(11):2013–2022. doi:10.1007/s00204-013-1046-0
18. Baylin SB (2005) DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2:S4–S11
19. Jin Z, Tamura G, Tsuchiya T, Sakata K, Kashiwaba M, Osakabe M, Motoyama T (2001) Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br J Cancer 85(1):69–73. doi:10.1054/bjoc.2001.1853
20. Silva J, Dominguez G, Villanueva M, Gonzalez R, Garcia J, Corbacho C, Provencio M, Espana P, Bonilla F (1999) Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Br J Cancer 80(8):1262
21. Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA (2001) Methylation associated inactivation of RASSF1A from region 3p21. 3 in lung, breast and ovarian tumours. Oncogene 20(12):1509–1518
22. Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P (2004) Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 10(18 Pt 1):6189–6193. doi:10.1158/1078-0432.ccr-04-0597
23. Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, Graff JR (2000) Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer. Cancer Res 60(16):4346–4348
24. Sirchia SM, Ferguson AT, Sironi E, Subramanyan S, Orlandi R, Sukumar S, Sacchi N (2000) Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells. Oncogene 19(12):1556–1563
25. Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG (1998) Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 58(20):4515–4518
26. Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J, Sukumar S (2001) Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res 61(6):2782–2787
27. Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, Garrett E, Argani P, Sukumar S (2004) Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 64(13):4442–4452. doi:10.1158/0008-5472.can-03-3341
28. Gort EH, Suijkerbuijk KP, Roothaan SM, Raman V, Vooijs M, van der Wall E, van Diest PJ (2008) Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer. Cancer Epidemiol Biomarkers Prev 17(12):3325–3330
29. Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, Terry MB, Eng SM, Wolff MS, Stellman SD, Kabat GC, Levin B, Bradlow HL, Hatch M, Beyea J, Camann D, Trent M, Senie RT, Garbowski GC, Maffeo C, Montalvan P, Berkowitz GS, Kemeny M, Citron M, Schnabe F, Schuss A, Hajdu S, Vincguerra V, Collman GW, Obrams GI (2002) The Long Island Breast Cancer STUDY Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 74(3):235–254
30. Xu X, Gammon MD, Zhang Y, Bestor TH, Zeisel SH, Wetmur JG, Wallenstein S, Bradshaw PT, Garbowski G, Teitelbaum SL, Neugut AI, Santella RM, Chen J (2009) BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat 115(2):397–404. doi:10.1007/s10549-008-0075-5
31. Liu ZJ, Maekawa M, Horii T, Morita M (2003) The multiple promoter methylation profile of PR gene and ERalpha gene in tumor cell lines. Life Sci 73(15):1963–1972
32. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Danenberg PV, Laird PW (1999) CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res 59(10):2302–2306
33. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28(8):E32
34. Gibson UE, Heid CA, Williams PM (1996) A novel method for real time quantitative RT-PCR. Genome Res 6(10):995–1001
35. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1):156–159. doi:10.1006/abio.1987.9999
36. Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, Makrigiorgos GM, Weisenberger DJ, Laird PW, Loda M, Fuchs CS (2006) Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn JMD 8(2):209–217. doi:10.2353/jmoldx.2006.050135
37. Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, Peters JH, DeMeester TR, Danenberg KD, Danenberg PV, Laird PW, Skinner KA (2000) Fields of aberrant CpG island hypermethylation in Barrett’s esophagus and associated adenocarcinoma. Cancer Res 60(18):5021–5026
38. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, Yu W, Rongione MA, Ekstrom TJ, Harris TB, Launer LJ, Eiriksdottir G, Leppert MF, Sapienza C, Gudnason V, Feinberg AP (2008) Intra-individual change over time in DNA methylation with familial clustering. JAMA 299(24):2877–2883. doi:10.1001/jama.299.24.2877
39. Hosmer D, Lemeshow S (1989) Applied Logsitic Regression, vol Book, Whole. Wiley, New York
40. Begg CB, Zhang ZF (1994) Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 3(2):173–175
41. Kleinbaum DG, Klein M (2002) Logistic regression: a self-learning text. Springer, New York
42. Khoury MJ, Flanders WD (1996) Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case–control studies with no controls! Am J Epidemiol 144(3):207–213
43. Chen KM, Stephen JK, Raju U, Worsham MJ (2011) Delineating an epigenetic continuum for initiation, transformation and progression to breast cancer. Cancers (Basel) 3(2):1580–1592. doi:10.3390/cancers3021580
44. Narayan S, Jaiswal AS, Balusu R (2005) Tumor suppressor APC blocks DNA polymerase beta-dependent strand displacement synthesis during long patch but not short patch base excision repair and increases sensitivity to methylmethane sulfonate. J Biol Chem 280(8):6942–6949. doi:10.1074/jbc.M409200200
45. Widschwendter M, Siegmund KD, Muller HM, Fiegl H, Marth C, Muller-Holzner E, Jones PA, Laird PW (2004) Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res 64(11):3807–3813. doi:10.1158/0008-5472.can-03-3852
46. McCarty KM, Santella RM, Steck SE, Cleveland RJ, Ahn J, Ambrosone CB, North K, Sagiv SK, Eng SM, Teitelbaum SL, Neugut AI, Gammon MD (2009) PAH–DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environ Health Perspect 117(4):552–558. doi:10.1289/ehp.0800119
47. Peluso M, Bollati V, Munnia A, Srivatanakul P, Jedpiyawongse A, Sangrajrang S, Piro S, Ceppi M, Bertazzi PA, Boffetta P, Baccarelli AA (2012) DNA methylation differences in exposed workers and nearby residents of the Ma Ta Phut industrial estate, Rayong, Thailand. Int J Epidemiol 41(6):1753–1760; discussion 1761–1753. doi:10.1093/ije/dys129
48. Pavanello S, Bollati V, Pesatori AC, Kapka L, Bolognesi C, Bertazzi PA, Baccarelli A (2009) Global and gene-specific promoter methylation changes are related to anti-B[a]PDE-DNA adduct levels and influence micronuclei levels in polycyclic aromatic hydrocarbon-exposed individuals. Int J Cancer 125(7):1692–1697. doi:10.1002/ijc.24492
49. Brooks J, Cairns P, Zeleniuch-Jacquotte A (2009) Promoter methylation and the detection of breast cancer. Cancer Causes Control 20(9):1539–1550. doi:10.1007/s10552-009-9415-y
50. Lewis CM, Cler LR, Bu DW, Zochbauer-Muller S, Milchgrub S, Naftalis EZ, Leitch AM, Minna JD, Euhus DM (2005) Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin Cancer Res 11(1):166–172
51. Cho YH, Yazici H, Wu HC, Terry MB, Gonzalez K, Qu M, Dalay N, Santella RM (2010) Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. Anticancer Res 30(7):2489–2496
52. Yauk CL, Polyzos A, Rowan-Carroll A, Kortubash I, Williams A, Kovalchuk O (2008) Tandem repeat mutation, global DNA methylation, and regulation of DNA methyltransferases in cultured mouse embryonic fibroblast cells chronically exposed to chemicals with different modes of action. Environ Mol Mutagen 49(1):26–35. doi:10.1002/em.20359
53. James SJ, Pogribny IP, Pogribna M, Miller BJ, Jernigan S, Melnyk S (2003) Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. J Nutr 133(11 Suppl 1):3740S–3747S
54. Herbstman JB, Tang D, Zhu D, Qu L, Sjodin A, Li Z, Camann D, Perera FP (2012) Prenatal exposure to polycyclic aromatic hydrocarbons, benzo[a]pyrene-DNA adducts, and genomic DNA methylation in cord blood. Environ Health Perspect 120(5):733–738. doi:10.1289/ehp.1104056
55. Savitz DA, Olshan AF (1995) Multiple comparisons and related issues in the interpretation of epidemiologic data. Am J Epidemiol 142(9):904–908